A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
about
Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplificationEarly steps of retrovirus replicative cycleRedefining the viral reservoirs that prevent HIV-1 eradicationViral and latent reservoir persistence in HIV-1-infected patients on therapyThe latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance.Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcomeAntiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi babyViral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDSG-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivoA novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.Autologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART.Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.Multiple independent lineages of HIV-1 persist in breast milk and plasma.A unified concept of HIV latency.Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.Latency in human immunodeficiency virus type 1 infection: no easy answers.Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivoGenetic therapy for HIV/AIDS.Clinical management of HIV drug resistance.The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in InfantsTemporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchPaucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradicationDynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age.Experimental approaches to the study of HIV-1 latency.Persistent HIV-1 replication maintains the tissue reservoir during therapyContinued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loadsImmunology of pediatric HIV infectionHIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography.HIV latency.Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1.
P2860
Q24634551-5B7E6BD0-AF7A-4E52-A97B-17601A6852CAQ24792862-873A0480-C427-40FA-B4AB-E41799FEB6EBQ26827255-FF4D1D39-3BFE-4424-9CAE-391E785E3705Q28469057-686AF86A-CC9A-4F93-B2E5-41C71DEB670DQ33212237-A866B32E-06F2-4DEB-91F8-99CE645B26B1Q33313038-37C9CADA-67DD-479F-B614-11E6D8C45687Q33521702-57494A79-ED85-4609-A010-4F97D773907CQ33557037-6DDEDE86-987A-4A37-876E-7572C14231DEQ33676630-AFAB5838-D668-4A98-A470-91FBF178F05FQ33718616-95565A38-6BF1-4604-AFDF-8D4687F4BDB2Q33724247-A4A7EC90-CC2D-46CF-9B94-417893E40D98Q33768729-8CE10D68-A813-4146-9071-6146F67F227AQ33843148-559C429E-8A17-42AF-BDE9-E12562575BE9Q33908838-3038F0A8-F350-4BB0-8882-7EE245780461Q34103202-6169CC78-5018-4B3F-9587-9E53B8464F35Q34344290-461E4754-2F10-462D-B6A1-6290E1F02850Q34345655-DCD2CE3F-0732-4EA8-8C9E-D3A5FE468029Q34544952-8BDC3326-6DFB-469C-AF3C-A90AA345FF39Q34571862-7B18CA86-169E-40DE-A924-4C3F39D0FD7FQ34857454-EC280DAD-AFA4-4B47-B4F6-8607A9735718Q35044157-E58E7033-6025-4C2D-9925-D45488A25ACFQ35149006-191A0A0D-77CB-4414-9E43-4AC6B1B8AC18Q35207524-FDD2C0EE-14EE-4702-A2CF-93DCBD7455B8Q35261045-7428AD80-2956-4A9B-B957-6892990722A9Q35917148-448A28D5-A163-415B-BE1C-5390D37F144FQ35996827-E432C7B9-C6A5-47B8-BDDE-B2B307CDE4CEQ36125264-62DA1F2F-4DC3-43AD-94ED-9CF8F5682D72Q36274030-430513F7-29CB-4A43-B466-D6C19304140AQ36311438-8422DC1B-C234-43B4-B382-0DDB1F4BF4C0Q36330062-29442A4F-F6F3-4189-AA51-E12F289EB818Q36390881-0DB1C949-0ECC-4ED0-B12C-12E73AC375C0Q36708954-9929D88B-4C1A-49E3-9C3B-C1B67233FFC1Q36897321-8F5F204F-5EE2-4FDF-99DA-EA7ED1B3B60CQ36943833-965AF5B0-8CF0-4B08-9E50-E904FC3C4E95Q37080573-1678BE4A-34B5-4477-93F0-8B1BD8319867Q37300442-0E0CDC2C-831F-47D6-B4B6-4C34801371E0Q37348467-6C1E35ED-55E0-476F-B868-C67BE0ADF7C9Q37392720-0D9F426F-EE5F-4F7E-8BE5-6A1851D2C618Q37974218-D30516BD-994A-44B8-BBE8-473434807F64Q38449098-3D835858-6FB4-4711-87DB-3CDAD46CBFBB
P2860
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@ast
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@en
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@nl
type
label
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@ast
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@en
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@nl
prefLabel
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@ast
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@en
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@nl
P2093
P2860
P3181
P356
P1476
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
@en
P2093
J B Margolick
K R Chadwick
R F Siliciano
P2860
P304
P3181
P356
10.1172/JCI9006
P407
P577
2000-04-01T00:00:00Z